About GRAIL
GRAIL is a company based in Menlo Park (United States) founded in 2016 was acquired by Illumina in September 2020.. GRAIL has raised $3.22 billion across 7 funding rounds from investors including Merck, Amazon and Tencent. The company has 1,000 employees as of December 31, 2024. GRAIL offers products and services including Galleri Test. GRAIL operates in a competitive market with competitors including Guardant Health, Color, Delfi Diagnostics, BillionToOne and Thrive Earlier Detection, among others.
- Headquarter Menlo Park, United States
- Employees 1000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Grail, Inc.
-
Annual Revenue
$125.59 M34.9as on Dec 31, 2024
-
Net Profit
$-2.03 B-38.3as on Dec 31, 2024
-
EBITDA
$-569.7 M10.74as on Dec 31, 2024
-
Total Equity Funding
$3.22 B (USD)
in 7 rounds
-
Latest Funding Round
$325 M (USD), Post-IPO
Oct 20, 2025
-
Investors
Merck
& 31 more
-
Employee Count
1000
as on Dec 31, 2024
-
Acquired by
Illumina
(Sep 20, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GRAIL
GRAIL is a publicly listed company on the NASDAQ with ticker symbol GRAL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of GRAIL
GRAIL offers a comprehensive portfolio of products and services, including Galleri Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test for detecting multiple cancers early through DNA analysis.
Unlock access to complete
Unlock access to complete
Funding Insights of GRAIL
GRAIL has successfully raised a total of $3.22B across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $325 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $325.0M
-
First Round
First Round
(10 Jan 2016)
- Investors Count 32
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - GRAIL | Valuation |
investors |
|
| Nov, 2019 | Amount | Series D - GRAIL | Valuation | PSP Investments , CPP Investments | |
| May, 2018 | Amount | Series C - GRAIL | Valuation | Ally Bridge Group , Hillhouse |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GRAIL
GRAIL has secured backing from 32 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Merck, Amazon and Tencent. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
Global private equity investments are managed with long-term focus.
|
Founded Year | Domain | Location | |
|
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GRAIL
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GRAIL
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Grail Comparisons
Competitors of GRAIL
GRAIL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Color, Delfi Diagnostics, BillionToOne and Thrive Earlier Detection, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Grail
Frequently Asked Questions about GRAIL
When was GRAIL founded?
GRAIL was founded in 2016.
Where is GRAIL located?
GRAIL is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Who is the current CEO of GRAIL?
Bob Ragusa is the current CEO of GRAIL.
Is GRAIL a funded company?
GRAIL is a funded company, having raised a total of $3.22B across 7 funding rounds to date. The company's 1st funding round was a Series C of $300M, raised on Jan 10, 2016.
How many employees does GRAIL have?
As of Dec 31, 2024, the latest employee count at GRAIL is 1,000.
What is the annual revenue of GRAIL?
Annual revenue of GRAIL is $125.59M as on Dec 31, 2024.
What does GRAIL do?
GRAIL was founded in 2016 in Menlo Park, United States, within the biotechnology sector focused on oncology. A platform for screening circulating tumor DNA to enable cancer detection is operated by the company. The Galleri test, designed as a pan-cancer screening tool, is developed by analyzing circulating nucleic acids from blood samples. Ultra-deep sequencing techniques are employed in this proprietary platform to quantify tumor DNA levels in patients.
Who are the top competitors of GRAIL?
GRAIL's top competitors include Guardant Health, BillionToOne and Delfi Diagnostics.
What products or services does GRAIL offer?
GRAIL offers Galleri Test.
Is GRAIL publicly traded?
Yes, GRAIL is publicly traded on NASDAQ under the ticker symbol GRAL.
Who are GRAIL's investors?
What is GRAIL's ticker symbol?
The ticker symbol of GRAIL is GRAL on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.